Financhill
Sell
39

ECOR Quote, Financials, Valuation and Earnings

Last price:
$5.34
Seasonality move :
6.54%
Day range:
$4.91 - $5.87
52-week range:
$4.47 - $19.49
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.61x
P/B ratio:
9.18x
Volume:
478.5K
Avg. volume:
152.1K
1-year change:
-26.43%
Market cap:
$40.1M
Revenue:
$25.2M
EPS (TTM):
-$1.56

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ECOR
electroCore
$6.9M -- 17.88% -- $21.88
APYX
Apyx Medical
$9.4M -$0.12 -3.81% -50.88% $4.00
ATEC
Alphatec Holdings
$168.2M -$0.12 22.9% -86.45% $18.21
KRMD
KORU Medical Systems
$8.9M -$0.03 12.21% -- $5.50
OWLT
Owlet
$18.1M -$0.24 7.17% -40% $10.33
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ECOR
electroCore
$5.40 $21.88 $40.1M -- $0.00 0% 1.61x
APYX
Apyx Medical
$1.43 $4.00 $54M -- $0.00 0% 1.12x
ATEC
Alphatec Holdings
$12.96 $18.21 $1.9B -- $0.00 0% 2.91x
KRMD
KORU Medical Systems
$2.95 $5.50 $136.1M -- $0.00 0% 3.86x
OWLT
Owlet
$5.27 $10.33 $87.1M -- $0.00 0% 0.79x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ECOR
electroCore
-- 1.885 -- 1.17x
APYX
Apyx Medical
76.45% 2.183 65.74% 4.49x
ATEC
Alphatec Holdings
118.58% 1.134 36.81% 1.54x
KRMD
KORU Medical Systems
0.83% 4.051 0.12% 1.92x
OWLT
Owlet
732.25% 0.285 20.55% 0.81x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ECOR
electroCore
$5.7M -$3.8M -163.87% -163.87% -56.88% -$4.4M
APYX
Apyx Medical
$5.7M -$3.1M -41.66% -140% -29.13% -$757K
ATEC
Alphatec Holdings
$116M -$31.7M -31.36% -691.37% -26.09% -$16.7M
KRMD
KORU Medical Systems
$6M -$1.2M -29.53% -29.85% -12.92% -$684.3K
OWLT
Owlet
$11.3M -$2.7M -- -- 19.09% -$6M

electroCore vs. Competitors

  • Which has Higher Returns ECOR or APYX?

    Apyx Medical has a net margin of -57.38% compared to electroCore's net margin of -44.01%. electroCore's return on equity of -163.87% beat Apyx Medical's return on equity of -140%.

    Company Gross Margin Earnings Per Share Invested Capital
    ECOR
    electroCore
    84.92% -$0.47 $4.4M
    APYX
    Apyx Medical
    60.07% -$0.10 $44.8M
  • What do Analysts Say About ECOR or APYX?

    electroCore has a consensus price target of $21.88, signalling upside risk potential of 286.67%. On the other hand Apyx Medical has an analysts' consensus of $4.00 which suggests that it could grow by 179.72%. Given that electroCore has higher upside potential than Apyx Medical, analysts believe electroCore is more attractive than Apyx Medical.

    Company Buy Ratings Hold Ratings Sell Ratings
    ECOR
    electroCore
    3 0 0
    APYX
    Apyx Medical
    1 2 0
  • Is ECOR or APYX More Risky?

    electroCore has a beta of 0.916, which suggesting that the stock is 8.354% less volatile than S&P 500. In comparison Apyx Medical has a beta of 1.117, suggesting its more volatile than the S&P 500 by 11.729%.

  • Which is a Better Dividend Stock ECOR or APYX?

    electroCore has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Apyx Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. electroCore pays -- of its earnings as a dividend. Apyx Medical pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ECOR or APYX?

    electroCore quarterly revenues are $6.7M, which are smaller than Apyx Medical quarterly revenues of $9.4M. electroCore's net income of -$3.9M is higher than Apyx Medical's net income of -$4.2M. Notably, electroCore's price-to-earnings ratio is -- while Apyx Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for electroCore is 1.61x versus 1.12x for Apyx Medical. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ECOR
    electroCore
    1.61x -- $6.7M -$3.9M
    APYX
    Apyx Medical
    1.12x -- $9.4M -$4.2M
  • Which has Higher Returns ECOR or ATEC?

    Alphatec Holdings has a net margin of -57.38% compared to electroCore's net margin of -30.68%. electroCore's return on equity of -163.87% beat Alphatec Holdings's return on equity of -691.37%.

    Company Gross Margin Earnings Per Share Invested Capital
    ECOR
    electroCore
    84.92% -$0.47 $4.4M
    ATEC
    Alphatec Holdings
    68.56% -$0.35 $462.5M
  • What do Analysts Say About ECOR or ATEC?

    electroCore has a consensus price target of $21.88, signalling upside risk potential of 286.67%. On the other hand Alphatec Holdings has an analysts' consensus of $18.21 which suggests that it could grow by 40.5%. Given that electroCore has higher upside potential than Alphatec Holdings, analysts believe electroCore is more attractive than Alphatec Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    ECOR
    electroCore
    3 0 0
    ATEC
    Alphatec Holdings
    6 1 0
  • Is ECOR or ATEC More Risky?

    electroCore has a beta of 0.916, which suggesting that the stock is 8.354% less volatile than S&P 500. In comparison Alphatec Holdings has a beta of 1.062, suggesting its more volatile than the S&P 500 by 6.249%.

  • Which is a Better Dividend Stock ECOR or ATEC?

    electroCore has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alphatec Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. electroCore pays -- of its earnings as a dividend. Alphatec Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ECOR or ATEC?

    electroCore quarterly revenues are $6.7M, which are smaller than Alphatec Holdings quarterly revenues of $169.2M. electroCore's net income of -$3.9M is higher than Alphatec Holdings's net income of -$51.9M. Notably, electroCore's price-to-earnings ratio is -- while Alphatec Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for electroCore is 1.61x versus 2.91x for Alphatec Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ECOR
    electroCore
    1.61x -- $6.7M -$3.9M
    ATEC
    Alphatec Holdings
    2.91x -- $169.2M -$51.9M
  • Which has Higher Returns ECOR or KRMD?

    KORU Medical Systems has a net margin of -57.38% compared to electroCore's net margin of -12.1%. electroCore's return on equity of -163.87% beat KORU Medical Systems's return on equity of -29.85%.

    Company Gross Margin Earnings Per Share Invested Capital
    ECOR
    electroCore
    84.92% -$0.47 $4.4M
    KRMD
    KORU Medical Systems
    62.75% -$0.03 $16.5M
  • What do Analysts Say About ECOR or KRMD?

    electroCore has a consensus price target of $21.88, signalling upside risk potential of 286.67%. On the other hand KORU Medical Systems has an analysts' consensus of $5.50 which suggests that it could grow by 86.44%. Given that electroCore has higher upside potential than KORU Medical Systems, analysts believe electroCore is more attractive than KORU Medical Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    ECOR
    electroCore
    3 0 0
    KRMD
    KORU Medical Systems
    4 1 0
  • Is ECOR or KRMD More Risky?

    electroCore has a beta of 0.916, which suggesting that the stock is 8.354% less volatile than S&P 500. In comparison KORU Medical Systems has a beta of 0.392, suggesting its less volatile than the S&P 500 by 60.809%.

  • Which is a Better Dividend Stock ECOR or KRMD?

    electroCore has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. KORU Medical Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. electroCore pays -- of its earnings as a dividend. KORU Medical Systems pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ECOR or KRMD?

    electroCore quarterly revenues are $6.7M, which are smaller than KORU Medical Systems quarterly revenues of $9.6M. electroCore's net income of -$3.9M is lower than KORU Medical Systems's net income of -$1.2M. Notably, electroCore's price-to-earnings ratio is -- while KORU Medical Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for electroCore is 1.61x versus 3.86x for KORU Medical Systems. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ECOR
    electroCore
    1.61x -- $6.7M -$3.9M
    KRMD
    KORU Medical Systems
    3.86x -- $9.6M -$1.2M
  • Which has Higher Returns ECOR or OWLT?

    Owlet has a net margin of -57.38% compared to electroCore's net margin of 14.33%. electroCore's return on equity of -163.87% beat Owlet's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    ECOR
    electroCore
    84.92% -$0.47 $4.4M
    OWLT
    Owlet
    53.67% $0.11 $1.9M
  • What do Analysts Say About ECOR or OWLT?

    electroCore has a consensus price target of $21.88, signalling upside risk potential of 286.67%. On the other hand Owlet has an analysts' consensus of $10.33 which suggests that it could grow by 96.08%. Given that electroCore has higher upside potential than Owlet, analysts believe electroCore is more attractive than Owlet.

    Company Buy Ratings Hold Ratings Sell Ratings
    ECOR
    electroCore
    3 0 0
    OWLT
    Owlet
    3 0 0
  • Is ECOR or OWLT More Risky?

    electroCore has a beta of 0.916, which suggesting that the stock is 8.354% less volatile than S&P 500. In comparison Owlet has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock ECOR or OWLT?

    electroCore has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Owlet offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. electroCore pays -- of its earnings as a dividend. Owlet pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ECOR or OWLT?

    electroCore quarterly revenues are $6.7M, which are smaller than Owlet quarterly revenues of $21.1M. electroCore's net income of -$3.9M is lower than Owlet's net income of $3M. Notably, electroCore's price-to-earnings ratio is -- while Owlet's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for electroCore is 1.61x versus 0.79x for Owlet. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ECOR
    electroCore
    1.61x -- $6.7M -$3.9M
    OWLT
    Owlet
    0.79x -- $21.1M $3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Ginkgo Bioworks Stock a Good Buy?
Is Ginkgo Bioworks Stock a Good Buy?

Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…

Why Mobileye Might Be Wall Street’s Next Big Surprise
Why Mobileye Might Be Wall Street’s Next Big Surprise

The trend to automate vehicles started long ago when adding…

Why Is Rigetti Stock Going Up?
Why Is Rigetti Stock Going Up?

Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Buy
71
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
81
SMLR alert for May 19

Semler Scientific [SMLR] is up 5.85% over the past day.

Sell
25
GLOB alert for May 19

Globant SA [GLOB] is up 4.02% over the past day.

Buy
94
HIMS alert for May 19

Hims & Hers Health [HIMS] is down 3.57% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock